Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.567
-0.003 (-0.49%)
Nov 21, 2024, 4:00 PM EST - Market closed
Bolt Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 22 | 43 | 49 | 183 | - | - | |
| Market Cap Growth | -37.18% | -13.15% | -73.20% | - | - | - | |
| Enterprise Value | -14 | -56 | -99 | -5 | - | - | |
| Last Close Price | 0.57 | 1.12 | 1.30 | 4.90 | - | - | |
| PS Ratio | 2.21 | 5.40 | 8.55 | 145.00 | - | - | |
| PB Ratio | 0.30 | 0.38 | 0.29 | 0.73 | - | - | |
| P/TBV Ratio | 0.34 | 0.38 | 0.29 | 0.73 | - | - | |
| Debt / Equity Ratio | 0.25 | 0.18 | 0.13 | 0.10 | 0.43 | 0.32 | |
| Asset Turnover | 0.07 | 0.04 | 0.02 | 0.01 | 0.00 | 0.01 | |
| Quick Ratio | 2.98 | 5.06 | 7.31 | 8.73 | 2.03 | 4.06 | |
| Current Ratio | 3.16 | 5.17 | 7.47 | 8.87 | 2.25 | 4.15 | |
| Return on Equity (ROE) | -64.99% | -48.69% | -41.79% | -71.52% | -212.22% | -136.76% | |
| Return on Assets (ROA) | -31.76% | -24.57% | -21.08% | -32.74% | -64.72% | -60.09% | |
| Return on Capital (ROIC) | -37.78% | -29.12% | -24.09% | -37.30% | -78.52% | -70.63% | |
| Earnings Yield | -300.09% | -162.73% | -179.94% | -53.96% | - | - | |
| FCF Yield | -282.04% | -163.99% | -160.25% | -32.52% | - | - | |
| Buyback Yield / Dilution | -1.02% | -1.21% | -12.54% | -1479.05% | -5.46% | -20.76% | |
| Total Shareholder Return | -1.02% | -1.21% | -12.54% | -1479.05% | -5.46% | -20.76% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.